A study published in Advanced Science used three AI models to screen thousands of approved drugs, identifying nine that inhibit Streptococcus pneumoniae, a bacterium increasingly resistant to antibiotics.
Rigid adherence thresholds in CMS's updated coverage decision leave doctors and suppliers guessing — and vulnerable patients at risk of losing a life-extending therapy